Shree Pushkar Q1FY27 revenue rises 10% to ₹280.1 crore; capex plan detailed
Shree Pushkar Chemicals & Fertilisers Ltd delivered a positive start to FY27 with Q1 revenue rising 10% to ₹280.1 crore and net profit increasing 9.4% to ₹229 crore. Despite a 17% drop in sales volumes, improved realizations drove top-line growth, keeping EBITDA margins stable at 11.4%. The company highlighted a robust expansion agenda with ₹512 crore in planned capex for new fertiliser, chemical, and solar capacities, funded via internal accruals and preferential issues.

*this image is generated using AI for illustrative purposes only.
Shree Pushkar Chemicals & Fertilisers reported a consolidated net profit of ₹229 crore for the first quarter ended June 30, 2026, an increase from ₹210 crore in the corresponding period of the previous fiscal year. This represents a year-on-year growth of 9.4%. On a quarter-on-quarter basis, net profit surged 78.2% from ₹129 crore in Q4FY26.
Revenue from operations grew to ₹280.1 crore, up from ₹254.5 crore year-on-year, marking a 10.0% increase. The company’s earnings before interest, taxes, depreciation, and amortisation (EBITDA) stood at ₹319 million, compared to ₹291 million in the prior year period, reflecting a 9.7% rise. Earnings before interest and taxes (EBIT) rose 12.9% to ₹30.5 crore, while profit before tax (PBT) increased 7.8% to ₹27.8 crore.
Financial Performance
| Metric: | Q1 FY27 | Q1 FY26 | Change | Q4 FY26 | QoQ Change |
|---|---|---|---|---|---|
| Revenue: | ₹280.1 crore | ₹254.5 crore | +10.0% | ₹218.2 crore | +28.4% |
| EBITDA: | ₹319 million | ₹291 million | +9.7% | ₹221 million | +44.3% |
| EBIT: | ₹30.5 crore | ₹27.0 crore | +12.9% | ₹18.3 crore | +66.4% |
| Net Profit: | ₹229 crore | ₹210 crore | +9.4% | ₹129 crore | +78.2% |
| EBITDA Margin: | 11.4% | 11.4% | Flat | 10.1% | Expanded |
The revenue growth outpaced the increase in net profit, indicating a slight compression in bottom-line efficiency despite top-line expansion. EBITDA margin remained relatively flat at 11.4%, compared to 11.4% in the previous year quarter but expanded significantly from 10.1% in Q4FY26. Gross profit margin contracted to 31.9% from 33.0% in Q1FY26 and 38.4% in Q4FY26.
Volume vs Value Dynamics
Despite the revenue growth, total sales volumes declined by 17.0% year-on-year to 75,640 metric tonnes from 91,125 metric tonnes in Q1FY26. The chemical segment saw a sharper volume drop of 38.6% to 9,113 metric tonnes, while fertiliser volumes fell 12.8% to 66,527 metric tonnes. However, improved realizations supported higher sales values. The chemical segment revenue grew 17.1% to ₹137.9 crore, and fertiliser revenue rose 4.0% to ₹142.2 crore. Fertilisers contributed 51% and chemicals 49% to total sales value.
Strategic Expansion & Capex Plan
The company detailed its strategic growth investments, outlining a total planned capex of ₹512 crore to expand capacity across its core businesses. This includes:
- Fertilisers: Unit 8 at Meghnagar (Madhya Pradesh) with a planned capex of ₹350 crore to add 3,00,000 MTPA capacity for complex fertilisers. Unit 6 at Ratnagiri is also expanding with ₹85 crore planned capex for 1,50,000 MTPA additional capacity.
- Chemicals: Unit 5 at Ratnagiri is undergoing expansion with ₹37 crore capex to add 72,000 MTPA capacity. An Acid Complex expansion at Ratnagiri involves ₹37 crore capex for 66,000 MTPA capacity.
- Solar Power: Expansion includes Solar Power Plant 2 at Nanded (₹35 crore capex for 10 MW DC) and Solar Power Plant 3 at Hisar (₹5 crore capex for 1.1 MW DC). The latter was commissioned in Q4FY26.
As of June 30, 2026, the company has incurred ₹209 crore towards these projects, with ₹303 crore outstanding. The growth is funded through internal accruals and a preferential allotment. Additionally, the company acquired approximately 30,000 square metres of land adjacent to its existing Unit 1 at Lote Parshuram for ₹93.3 million to support future expansion plans.
What the Numbers Show
The divergence between declining volumes (-17.0%) and rising revenue (+10.0%) indicates that price realizations or product mix shifts drove the top-line growth rather than volume expansion. The stability in EBITDA margin (11.4% vs 11.4%) alongside this dynamic suggests that cost structures scaled proportionally with the higher-value sales. However, the net profit growth of 9.4% lagged behind both revenue and EBITDA growth (9.7%), implying that non-operating expenses or tax provisions may have absorbed some of the operational gains. With a net debt-to-equity ratio of (0.01)x as of FY26, the company maintains a strong balance sheet to fund its ₹512 crore capex pipeline without significant leverage pressure.
Historical Stock Returns for Shree Pushkar Chemicals
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -3.07% | -4.99% | -4.00% | +15.22% | +1.97% | +148.85% |
How might the significant year-on-year decline in sales volumes (-17.0%) impact the company's market share and long-term demand sustainability in the chemical and fertiliser sectors?
What are the expected timelines for commissioning the new capacity expansions, and how will this affect near-term cash flow given the ₹303 crore outstanding capex?
Can the company sustain the current EBITDA margin of 11.4% as it scales up production, or will increased operational complexity from new units pressure profitability?


































